The effects of mannitol on the transport of ciprofloxacin across respiratory epithelia

Molecular Pharmaceutics

Volumn 10, Issue 8, 2013, Pages 2915-2924

  Ong, Hui Xin ^a   Traini, Daniela ^a   Salama, Rania ^a   Anderson, Sandra D ^b   Daviskas, Evangelia ^b   Young, Paul M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Calu 3; ciprofloxacin; disodium cromoglycate; furosemide; mannitol; transport

Indexed keywords

CIPROFLOXACIN; CROMOGLYCATE DISODIUM; FUROSEMIDE; MANNITOL;

APICAL SURFACE LIQUID; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EFFECT; DRUG FORMULATION; DRUG POTENTIATION; DRUG TRANSPORT; DRY POWDER; PARAMETERS; PH; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SPRAY DRYING;

BIOLOGICAL TRANSPORT; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; HUMANS; MANNITOL; PARTICLE SIZE; RESPIRATORY MUCOSA;

EID: 84881365375     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400030n     Document Type: Article

References (58)

1. Barker, A. F. Bronchiectasis N. Engl. J. Med. 2002, 346 (18) 1383-1393
2. Murray, T. S.; Egan, M.; Kazmierczak, B. I. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients Curr. Opin. Pediatr. 2007, 19 (1) 83
3. Barker, A. F.; Couch, L.; Fiel, S. B.; Gotfried, M. H.; Ilowite, J.; Meyer, K. C.; O'Donnel, A.; Sahn, S. A.; Smith, L. J.; Steward, J. O. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis Am. J. Respir. Crit. Care Med. 2000, 162 (2) 481-485
4. Geller, D. E. Aerosol antibiotics in cystic fibrosis Resp. Care 2009, 54 (5) 658-670
5. Yang, Y.; Tsifansky, M. D.; Shin, S.; Lin, Q.; Yeo, Y. Mannitol-Guided delivery of ciprofloxacin in artificial cystic fibrosis mucus model Biotechnol. Bioeng. 2011, 108 (6) 1441-1449
6. Anderson, P. Emerging therapies in cystic fibrosis Ther. Adv. Respir. Dis. 2010, 4 (3) 177-185
7. Saiman, L.; Marshall, B. C.; Mayer-Hamblett, N.; Burns, J. L.; Quittner, A. L.; Cibene, D. A.; Coquillette, S.; Fieberg, A. Y.; Accurso, F. J.; Campbell, P. W., III Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa J. Am. Med. Assoc. 2003, 290 (13) 1749-1756
8. Ramsey, B. W.; Pepe, M. S.; Quan, J. M.; Otto, K. L.; Montgomery, A. B.; Williams-Warren, J.; Vasiljev-K, M.; Borowitz, D.; Bowman, C. M.; Marshall, B. C. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis N. Engl. J. Med. 1999, 340 (1) 23-30
9. Knechtel, S. A.; Klepser, M. E. Safety of aerosolized amphotericin B Expert Opin. Drug Saf. 2007, 6 (5) 523-532
10. Döring, G.; Flume, P.; Heijerman, H.; Elborn, J. S. Treatment of lung infection in patients with cystic fibrosis: Current and future strategies J. Cystic Fibrosis 2012, 11 (6) 461-479
11. Schuster, A.; Haliburn, C.; Döring, G.; Goldman, M. H. Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study Thorax 2013, 68 (4) 344-350
12. Lands, L. C.; Milner, R.; Cantin, A. M.; Manson, D.; Corey, M. High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial J. Pediatr. 2007, 151 (3) 249-254
13. Flume, P. A.; O'Sullivan, B. P.; Robinson, K. A.; Goss, C. H.; Mogayzel, P. J.; Willey-Courand, D. B.; Bujan, J.; Finder, J.; Lester, M.; Quittell, L. Cystic fibrosis pulmonary guidelines chronic medications for maintenance of lung health Am. J. Respir. Crit. Care Med. 2007, 176 (10) 957-969
14. Van Haren, E.; Lammers, J.; Festen, J.; Heijerman, H.; Groot, C.; Van Herwaarden, C. The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis Resp. Med. 1995, 89 (3) 209-214
15. Halfhide, C.; Evans, H.; Couriel, J. Inhaled bronchodilators for cystic fibrosis. Cochrane Database Syst. Rev. 2005, (4), CD003428.
16. Wood, A. J. J.; Ramsey, B. W. Management of pulmonary disease in patients with cystic fibrosis N. Engl. J. Med. 1996, 335 (3) 179-188
17. Ibrahim, B. M.; Tsifansky, M. D.; Yang, Y.; Yeo, Y. Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease Expert Opin. Drug Delivery 2011, 8 (4) 451-466
18. Henke, M. O.; Ratjen, F. Mucolytics in cystic fibrosis Paediatr. Respir. Rev. 2007, 8 (1) 24-29
19. Elkins, M. R.; Robinson, M.; Rose, B. R.; Harbour, C.; Moriarty, C. P.; Marks, G. B.; Belousova, E. G.; Xuan, W.; Bye, P. T. P. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis N. Engl. J. Med. 2006, 354 (3) 229-240
20. Abbott, J.; Hart, A. Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: a critical review Health Qual. Life Outcomes 2005, 3, 19
21. Heaf, D.; Webb, G.; Matthew, D. In vitro assessment of combined antibiotic and mucolytic treatment for Pseudomonas aeruginosa infection in cystic fibrosis Arch. Dis. Child. 1983, 58 (10) 824-826
22. Tramper-Stranders, G. A.; Wolfs, T. F.; van Haren Noman, S.; van Aalderen, W. M.; Nagelkerke, A. F.; Nuijsink, M.; Kimpen, J. L.; van der Ent, C. K. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis Thorax 2010, 65 (10) 915-920
23. Conley, J.; Yang, H.; Wilson, T.; Blasetti, K.; Di Ninno, V.; Schnell, G.; Wong, J. P. Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice Antimicrob. Agents Chemother. 1997, 41 (6) 1288-1292
24. Adi, H.; Young, P. M.; Chan, H. K.; Agus, H.; Traini, D. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease Eur. J. Pharm. Sci. 2010, 40 (3) 239-247
25. Ong, H. X.; Traini, D.; Cipolla, D.; Gonda, I.; Bebawy, M.; Agus, H.; Young, P. M. Liposomal Nanoparticles Control the Uptake of Ciprofloxacin Across Respiratory Epithelia Pharm. Res. 2012, 1-12
26. Cipolla, D. C.; Redelmeier, T.; Eastman, S.; Bruinenberg, P.; Gonda, I. In Liposomes, niosomes and proniosomes-a critical update of their (commercial) development as inhaled products; Respiratory Drug Delivery Europe 2011, Berlin, Germany, 2010; Dalby, R. N.; Byron, P. R.; Peart, J.; Suman, J. D.; Farr, S. J.; Young, P. M., Eds.; Davis Healthcare Int'l Publishing: Rover Grove, IL, Berlin, Germany; pp 41-54.
27. Brannan, J. D.; Koskela, H.; Anderson, S. D.; Chew, N. Responsiveness to mannitol in asthmatic subjects with exercise-and hyperventilation-induced asthma Am. J. Respir. Crit. Care Med. 1998, 158 (4) 1120-1126
28. Daviskas, E.; Anderson, S. D.; Eberl, S.; Chan, H. K.; Bautovich, G. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis Am. J. Respir. Crit. Care Med. 1999, 159 (6) 1843-1848
29. Robinson, M.; Daviskas, E.; Eberl, S.; Baker, J.; Chan, H. K.; Anderson, S. D.; Bye, P. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study Eur. Respir. J. 2001, 14 (3) 678-685
30. Jaques, A.; Daviskas, E.; Turton, J. A.; McKay, K.; Cooper, P.; Stirling, R. G.; Robertson, C. F.; Bye, P. T. P.; LeSouëf, P. N.; Shadbolt, B.; Anderson, S. D.; Charlton, B. Inhaled mannitol improves lung function in cystic fibrosis Chest 2008, 133 (6) 1388-1396
31. Daviskas, E.; Anderson, S. D.; Brannan, J. D.; Chan, H.; Eberl, S.; Bautovich, G. Inhalation of dry-powder mannitol increases mucociliary clearance Eur. Respir. J. 1997, 10 (11) 2449-2454
32. Ong, H. X.; Traini, D.; Bebawy, M.; Young, P. M. Epithelial profiling of antibiotic controlled release respiratory formulations Pharm. Res. 2011, 28 (9) 2327-2338
33. Grainger, C. I.; Greenwell, L. L.; Lockley, D. J.; Martin, G. P.; Forbes, B. Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier Pharm. Res. 2006, 23 (7) 1482-1490
34. Haghi, M.; Young, P. M.; Traini, D.; Jaiswal, R.; Gong, J.; Bebawy, M. Time-and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model Drug Dev. Ind. Pharm. 2010, 36 (10) 1207-1214
35. Cavet, M. E.; West, M.; Simmons, N. L. Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells Antimicrob. Agents Chemother. 1997, 41 (12) 2693-2698
36. Mathias, N. R.; Timoszyk, J.; Stetsko, P. I.; Megill, J. R.; Smith, R. L.; Wall, D. A. Permeability Characteristics of Calu-3 Human Bronchial Epithelial Cells: In Vitro-In Vivo Correlation to Predict Lung Absorption in Rats J. Drug Targeting 2002, 10 (1) 31-40
37. Bur, M.; Lehr, C. M. Pulmonary cell culture models to study the safety and efficacy of innovative aerosol medicines Expert Opin. Drug Delivery 2008, 5 (6) 641-652
38. Grainger, C.; Greenwell, L.; Martin, G.; Forbes, B. The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa Eur. J. Pharm. Biopharm. 2009, 71 (2) 318-324
39. Moore, J. W.; Flanner, H. H. Mathematical comparison of dissolution profiles Pharm. Tech. 1996, 20 (6) 64-74
40. Polli, J. E.; Rekhi, G. S.; Augsburger, L. L.; Shah, V. P. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets J. Pharm. Sci. 1997, 86 (6) 690-700
41. Labiris, N.; Dolovich, M. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications Br. J. Clin. Pharmacol. 2003, 56 (6) 588-599
42. Anderson, S. D.; Rodwell, L. T.; Daviskas, E.; Spring, J. F.; du Toit, J. The protective effect of nedocromil sodium and other drugs on airway narrowing provoked by hyperosmolar stimuli: A role for the airway epithelium? J. Allergy Clin. Immunol. 1996, 98 (5) S124-S134
43. Anderson, S. D.; du Toit, J. I.; Rodwell, L. T.; Jenkins, C. R. Acute effect of sodium cromoglycate on airway narrowing induced by 4.5% saline aerosol. Outcome before and during treatment with aerosol corticosteroids in patients with asthma Chest 1994, 105 (3) 673-680
44. Bianco, S.; Robuschi, M.; Vaghi, A.; Pasargiklian, M. Prevention of exercise-induced bronchoconstriction by inhaled frusemide Lancet 1988, 332 (8605) 252-255
45. Rodwell, L.; Anderson, S.; Du Toit, J.; Seale, J. The effect of inhaled frusemide on airway sensitivity to inhaled 4.5% sodium chloride aerosol in asthmatic subjects Thorax 1993, 48 (3) 208-213
46. Barnes, P. Diuretics and asthma Thorax 1993, 48 (3) 195
47. Caco, A. I.; Varanda, F.; Pratas de Melo, M. J.; Dias, A. M. A.; Dohrn, R.; Marrucho, I. M. Solubility of Antibiotics in Different Solvents. Part II. Non-Hydrochloride Forms of Tetracycline and Ciprofloxacin Ind. Eng. Chem. Res. 2008, 47 (21) 8083-8089
48. Varanda, F.; Maria, J.; de Melo, P.; Ana, I.; Dohrn, R.; Makrydaki, F. A.; Voutsas, E.; Tassios, D.; Marrucho, I. M. Solubility of antibiotics in different solvents. 1. Hydrochloride forms of tetracycline, moxifloxacin, and ciprofloxacin Ind. Eng. Chem. Res. 2006, 45 (18) 6368-6374
49. Fischer, H.; Widdicombe, J. H. Mechanisms of acid and base secretion by the airway epithelium J. Membr. Biol. 2006, 211 (3) 139-150
50. Haghi, M.; Traini, D.; Bebawy, M.; Young, P. M. Deposition, Diffusion and Transport Mechanism of Dry Powder Microparticulate Salbutamol, at the Respiratory Epithelia Mol. Pharmaceutics 2012, 9 (6) 1717-1726
51. Ng, A. W.; Bidani, A.; Heming, T. A. Innate host defense of the lung: effects of lung-lining fluid pH Lung 2004, 182 (5) 297-317
52. Vasudevan, D.; Bruland, G. L.; Torrance, B. S.; Upchurch, V. G.; MacKay, A. A. pH-dependent ciprofloxacin sorption to soils: Interaction mechanisms and soil factors influencing sorption Geoderma 2009, 151 (3) 68-76
53. Hirsh, A. J. Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents Adv. Drug Delivery Rev. 2002, 54 (11) 1445-1462
54. Ong, H. X.; Traini, D.; Bebawy, M.; Young, P. M. Ciprofloxacin Is Actively Transported across Bronchial Lung Epithelial Cells Using a Calu-3 Air Interface Cell Model Antimicrob. Agents Chemother. 2013, 57 (6) 2535-2540
55. Nilsson, H.; Dragomir, A.; Ahlander, A.; Johannesson, M.; Roomans, G. M. Effects of hyperosmotic stress on cultured airway epithelial cells J. Cell Tissue Res. 2007, 330 (2) 257-269
56. Högman, M.; Mörk, A. C.; Roomans, G. Hypertonic saline increases tight junction permeability in airway epithelium Eur. Respir. J. 2002, 20 (6) 1444-1448
57. Willumsen, N. J.; Davis, C. W.; Boucher, R. C. Selective response of human airway epithelia to luminal but not serosal solution hypertonicity. Possible role for proximal airway epithelia as an osmolality transducer J. Clin. Invest. 1994, 94 (2) 779
58. Mukherjee, T.; Squillantea, E.; Gillespieb, M.; Shao, J. Transepithelial Electrical Resistance is Not a Reliable Measurement of the Caco-2 Monolayer Integrity in Transwell Drug Delivery 2004, 11 (1) 11-18